Inactive Instrument

Highlights Alliance Pharma plc

Equities

APH

GB0031030819

Pharmaceuticals

Highlights

Alliance Pharma Delists from London Bourse's AIM After Acquisition	05-15	MT
Aegros Bidco Completes Takeover of Alliance Pharma	05-14	MT
Alliance Pharma Says Aegros Bidco Recommends Acquisition Of Alliance Pharma	05-14	RE
An undisclosed funds, managed by DBAY Advisors Limited, An undisclosed funds, managed by Baring Asset Management Limited, Edmond De Rothschild Equity Strategies IV Fund, a fund managed by Edmond de Rothschild Private Equity Management Ltd. and an undisclosed buyer completed the acquisition of remaining 71.9% stake in Alliance Pharma plc from Andrew Franklin, Richard Jones, Nick Sedgwick, Slater Investments Limited and others.	05-13	CI
Aegros' Takeover of Alliance Pharma Sanctioned by Court	05-13	MT
Alliance Pharma loss narrows in 2024 due to reduced impairment charges	04-08	AN
Alliance Pharma Says Group Performance In Three Months To End March In-Line With Expectations	04-08	RE
Alliance Pharma plc Reports Earnings Results for the Full Year Ended December 31, 2024	04-08	CI
Alliance Pharma-Aegros Bidco Deal Secures Regulatory Clearances	03-21	MT
Aegros Bidco's Bid Gets Alliance Pharma Shareholders' Nod	03-13	MT
PRESS DIGEST-British Business - March 11	03-11	RE
Deals of the day-Mergers and acquisitions	03-10	RE
Alliance Pharma board backs final GBP362 million takeover bid	03-10	AN
Alliance Pharma Receives Final Increased Takeover Offer from Aegros Bidco	03-10	MT
Deals of the day-Mergers and acquisitions	03-10	RE
UK Stocks-Factors to watch on March 10	03-10	RE
UK's Alliance Pharma accepts DBAY's sweetened final offer	03-10	RE
Alliance Pharma Agrees To Final Cash Offer From DBAY	03-10	RE
UK's Alliance Pharma agrees to final cash offer from asset management firm DBAY	03-10	RE
UK's Alliance Pharma agrees to final cash offer from asset management firm DBAY	03-10	RE
Alliance Pharma expects to post flat annual profit, revenue decline	01-31	AN
Jefferies likes Volex; UBS raises Next	01-31	AN
Alliance Pharma plc Announces Unaudited Revenue Results for the Year Ended 31 December 2024	01-31	CI
AIM WINNERS & LOSERS: Anpario expects 2024 earnings beat	01-10	AN
Alliance Pharma agrees GBP350 million takeover by largest shareholder	01-10	AN

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Alliance Pharma plc

Equities

APH

GB0031030819

Pharmaceuticals

Highlights

Filters